Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer (NCT03624660)
A Phase II Study of Dose-Escalated Proton-Based Radiation Therapy Delivered With a Simultaneous Integrated Boost (SIB) to Intraprostatic Tumors (IPT) Visible on Pretreatment Magnetic Resonance Image
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this research study is to determine if dose-escalated proton radiation therapy is a good way to treat high-risk prostate cancer. The study features hypofractionation and a simultaneous integrated boost to the magnetic resonance imaging (MRI) identified intraprostatic tumor (IPT) as a method of dose-escalating radiation therapy. The study will include patients with high-risk prostate cancer who are at the highest risk for recurrence. Radiation therapy will be delivered over the course of 8-9 weeks. Additionally, androgen deprivation therapy (ADT) will be started 8-10 weeks prior to starting radiation and continued for a total of 18 months if the patient decides to receive ADT.
Who can join: Review the eligibility criteria below.
Location: University of Florida Health Proton Therapy Institute — Jacksonville, Florida
Age range: 18 Years to 100 Years
🧪 Interventions in This Study
- HR-A (RADIATION)
- HR-B (RADIATION)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Florida Health Proton Therapy Institute — Jacksonville, Florida
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Adenocarcinoma of the Prostate
- Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer — Los Angeles, California
- Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer — Philadelphia, Pennsylvania
- Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer — Los Angeles, California
Explore by condition: All Adenocarcinoma of the Prostate clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.